CRISPR Therapeutics
$8.87 B
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Share price
Change (1 day)
Change (1 year)

Revenue for CRISPR Therapeutics (CRSP)

Revenue in 2021 (TTM): $1.1 M

According to CRISPR Therapeutics's latest financial reports the company's current revenue (TTM) is $1.1 M. In 2020 the company made a revenue of $0.71 M a decrease over the years 2019 revenue that were of $0.28 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expences are substracted.

Revenue history for CRISPR Therapeutics from 2016 to 2021

Year Revenue Change
2021 (TTM)$1.1 M53.13%
2020$0.71 M-99.75%
2019$0.28 B9169.85%
2018$3.12 M-92.38%
2017$0.04 B693.9%
2016$5.16 M